Osteonecrosis of the jaw in sweden associated with the oral use of bisphosphonate

Journal of Oral and Maxillofacial Surgery

Volumn 72, Issue 1, 2014, Pages 76-82

  Ulmner, Mattias ^a   Jarnbring, Fredrik ^a   Törring, Ove ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; IBANDRONIC ACID; RISEDRONIC ACID;

ADULT; AGED; ARTICLE; FEMALE; HEAD; HUMAN; INCIDENCE; JAW OSTEONECROSIS; MAJOR CLINICAL STUDY; MALE; NECK; RADIOTHERAPY; SWEDEN; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; AGE FACTORS; AGED; AGED, 80 AND OVER; ALENDRONATE; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; CROSS-SECTIONAL STUDIES; DIPHOSPHONATES; FEMALE; HUMANS; INCIDENCE; JAW DISEASES; MALE; MANDIBULAR DISEASES; MAXILLARY DISEASES; MIDDLE AGED; OSTEONECROSIS; SEX FACTORS; SWEDEN;

EID: 84890565032     PISSN: 02782391     EISSN: 15315053     Source Type: Journal    
DOI: 10.1016/j.joms.2013.06.221     Document Type: Article

References (24)

1. A.A. Khan, L.P. Rios, and G.K. Sandor Bisphosphonate-associated osteonecrosis of the jaw in Ontario: A survey of oral and maxillofacial surgeons J Rheumatol 38 2011 1396
2. I.R. Reid, and J. Cornish Epidemiology and pathogenesis of osteonecrosis of the jaw Nat Rev Rheumatol 8 2012 90
3. L.A. Assael Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: Clinical findings, assessment of risks, and preventive strategies J Oral Maxillofac Surg 67 5 Suppl 2009 35
4. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic J Oral Maxillofac Surg 61 2003 1115
5. S.K. Kumar, M. Meru, and P.P. Sedghizadeh Osteonecrosis of the jaws secondary to bisphosphonate therapy: A case series J Contemp Dent Pract 9 2008 63
6. A. Bamias, E. Kastritis, and C. Bamia Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors J Clin Oncol 23 2005 8580
7. O. Filleul, E. Crompot, and S. Saussez Bisphosphonate-induced osteonecrosis of the jaw: A review of 2,400 patient cases J Cancer Res Clin Oncol 136 2010 1117
8. S.L. Ruggiero, B. Mehrotra, T.J. Rosenberg, and S.L. Engroff Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases J Oral Maxillofac Surg 62 2004 527
9. S. Khosla, D. Burr, and J. Cauley Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research J Bone Miner Res 22 2007 1479
10. S.L. Ruggiero, T.B. Dodson, and L.A. Assael American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws - 2009 update J Oral Maxillofac Surg 67 5 Suppl 2009 2
11. G. Campisi, S. Fedele, and G. Colella Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw J Rheumatol 36 2009 451
12. R.E. Marx, J.E. Cillo Jr, and J.J. Ulloa Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment J Oral Maxillofac Surg 65 2007 2397
13. F. Jarnbring, M. Ulmner, J. Blomlof, and P. Ljungman [Diphosphonates can cause necrosis of the jaw: Patients with malignant skeletal diseases are at risk] Lakartidningen 103 2006 1741
14. WHO Collaborating Centre for Drug Statistics Methodology 2009 Norwegian Institute of Public Health Oslo, Norway Available at: http://www.whocc.no/ddd/ definition-and-general-considera/
15. Press release From Statistics Sweden 2009-02-17, 09:30, no. 2009 2009 39 Available at: http://www.scb.se/Pages/PressRelease-262430.aspx Accessed February 17, 2009
16. W.E. Bacon, S. Maggi, and A. Looker International comparison of hip fracture rates in 1988-89 Osteoporos Int 6 1996 69
17. Medical Products Agency [Treatment of osteoporosis] [Information from MPA] 2007 Medical Products Agency Uppsala, Sweden 19 29 [Swedish]
18. National Board of Health and Welfare: [National Guidelines for Musculoskeletal Disorders. Osteoporosis.] 2012 National Board of Health and Welfare Stockholm, Sweden [Swedish]
19. National Board of Health And Welfare [National Planning Support. Annual report 2011: An Analysis of Midwives, Nurses, Doctors, Dental Hygienists and Dentists Labor Market.] National Board of Health and welfare, Stockholm Sweden 2011[Swedish]
20. T. Mavrokokki, A. Cheng, B. Stein, and A. Goss Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia J Oral Maxillofac Surg 65 2007 415
21. J.C. Lo, F.S. O'Ryan, and N.P. Gordon Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure J Oral Maxillofac Surg 68 2010 243
22. P.P. Sedghizadeh, K. Stanley, and M. Caligiuri Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: An institutional inquiry J Am Dent Assoc 140 2009 61
23. E. Landfeldt, O. Strom, S. Robbins, and F Borgstrom Adherence to treatment of primary osteoporosis and its association to fractures - the Swedish Adherence Register Analysis (SARA) Osteoporos Int 23 2012 433
24. Central Intelligence Agency Country comparison: Life expectancy at birth, in The World Factbook 2012 Available at: https://www.cia.gov/library/ publications/the-world-factbook/rankorder/2102rank.html#top Accessed July 13, 2012